Collaboration Details

Print  Close


Title of Collaborative Activity:

FNIH Biomarkers Consortium

Description of Collaborative Activity:

The Biomarkers Consortium is a major public-private biomedical research partnership managed by the Foundation for the National Institutes of Health (FNIH) with broad participation from stakeholders across the health field, including government, industry, academia, patient advocacy, and other not-for-profit organizations. In addition to the FNIH, founding members include the National Institutes of Health, Food and Drug Administration, and the Pharmaceutical Research and Manufacturers of America. The Biomarkers Consortium brings together the expertise and resources of various partners to rapidly identify, develop, and qualify potential high-impact biomarkers to enable improvements in drug development, clinical care, and regulatory decision-making.

Type of Collaborative Activity:

Research Initiative

Year the Collaborative Activity Originated:

2006

NIH Participating Institutes/Centers/Office of the Director:

NCATS, NCI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NICHD, NIDA, NIDCR, NIDDK, NIEHS, NIMH, NINDS

HHS Agency Collaborators on this Activity:

CMS, FDA